Considerations for the successful development and launch of personalised nutrigenomic foods

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 622, Issue 1-2, 2007, Pages 117-121

  Sutton, Kevin H ^a  

^a THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

Author keywords

Crohn's; Customisation; Food; Functional; Nutrigenomic; Personalised

Indexed keywords

ARTICLE; CONSUMER; CROHN DISEASE; ENTERITIS; ETHICS; FOOD INDUSTRY; FOOD INTAKE; GENE; GENOTYPE; HUMAN; MARKETING; NUTRIENT; NUTRIGENOMICS; PRIORITY JOURNAL;

DIET; GENOMICS; HEALTH FOOD; HUMANS; NUTRITION PHYSIOLOGY; NUTRITION POLICY;

EID: 34547658911     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.03.007     Document Type: Article

References (12)

1. J. Mellentin, Ten Key Trends in Functional Foods 2007, New Nutrition Business. New Nutrition Business, The Centre for Food & Health Studies, Crown House, 72 Hammersmith Road, London W14 8TH, UK (www.new-nutrition.com), 2001.
2. International Food Information Council (IFIC), 1100 Connecticut Avenue, NW, Suite 430, Washington, DC 20036, USA (www.ific.org/research/funcfoodsres02.cfm).
3. International Food Information Council (IFIC), 1100 Connecticut Avenue, NW, Suite 430, Washington, DC 20036, USA (www.ific.org/research/funcfoodsres05.cfm).
4. Podolsky D.K. Inflammatory bowel disease. N. Engl. J. Med. 347 (2002) 417-429
5. Franchimont D., Vermeire S., El Housni H., Pierik M., Van Steen K., Gustot T., Quertinmont E., Abramowicz M., Van Gossum A., Deviere J., and Rutgeerts P. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor [TLR]-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53 (2004) 987-992
6. Torok H.P., Glas J., Tonenchi L., Bruennler G., and Folwaczny C. Crohn's disease is associated with a toll like receptor-9 polymorphism. Gastroenterology 127 (2004) 365-366
7. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., and Cho J.H. A frame-shift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
8. Functional Foods and Beverages, BCC Research, October 1, 2003, 165 pp., BCC Research, 40 Washington Street, Suite 110, Wellesley, MA 02481, USA (www.bccresearch.com).
9. Food Standards Australia New Zealand (FSANZ), P.O. Box 7186, Canberra, ACT 2610, Australia. Australia New Zealand Food Standards Code (www.foodstandards.gov.au/thecode/foodstandardscode.cfm).
10. Lamartiniere C.A., Cotroneo M.S., Fritz W.A., Wang J., Mentor-Marcel R., and Elgavish A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J. Nutr. 132 (2002) 552S-558S
11. Zhou J.R., Yu L., Zhong Y., and Blackburn G.L. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J. Nutr. 133 (2003) 516-521
12. Castle D., and Ries N. Ethical, legal and social issues in nutrigenomics: The challenges of regulating service delivery and building health professional capacity. Mutat. Res. 622 (2007) 138-143